ATE176461T1 - Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte - Google Patents

Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte

Info

Publication number
ATE176461T1
ATE176461T1 AT94931136T AT94931136T ATE176461T1 AT E176461 T1 ATE176461 T1 AT E176461T1 AT 94931136 T AT94931136 T AT 94931136T AT 94931136 T AT94931136 T AT 94931136T AT E176461 T1 ATE176461 T1 AT E176461T1
Authority
AT
Austria
Prior art keywords
enantiemeric
analogues
leucine
amino acid
intermediate products
Prior art date
Application number
AT94931136T
Other languages
English (en)
Inventor
Nicholas Turner
James Winterman
Raymond Mccague
Original Assignee
Chirotech Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chirotech Technology Ltd filed Critical Chirotech Technology Ltd
Application granted granted Critical
Publication of ATE176461T1 publication Critical patent/ATE176461T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT94931136T 1993-11-01 1994-11-01 Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte ATE176461T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322472A GB9322472D0 (en) 1993-11-01 1993-11-01 Chiral compounds and their preparation

Publications (1)

Publication Number Publication Date
ATE176461T1 true ATE176461T1 (de) 1999-02-15

Family

ID=10744442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931136T ATE176461T1 (de) 1993-11-01 1994-11-01 Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte

Country Status (10)

Country Link
US (1) US6180374B1 (de)
EP (1) EP0726891B1 (de)
JP (1) JPH09504304A (de)
AT (1) ATE176461T1 (de)
AU (1) AU676786B2 (de)
CA (1) CA2173205A1 (de)
DE (1) DE69416424T2 (de)
ES (1) ES2128592T3 (de)
GB (1) GB9322472D0 (de)
WO (1) WO1995012573A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529211C2 (de) * 1995-08-09 1999-01-14 Degussa Verfahren zur Herstellung von (R)-tertiär-Leucin
AU725852B2 (en) * 1996-04-02 2000-10-19 Bayer Aktiengesellschaft Substituted phenylketoenols as pesticides and herbicides
GB9607458D0 (en) 1996-04-10 1996-06-12 Zeneca Ltd Enzymatic process for stereoselective preparation of therapeutic amides
US6130337A (en) * 1997-04-11 2000-10-10 Board Of Trustees Of Leland Stanford Junior University Enantiomerically enriched α,α-distributed amino acids and method
JP2000319241A (ja) * 1999-04-28 2000-11-21 Ihara Chem Ind Co Ltd フェニルアルカン酸アミド化合物の製造方法
US8183408B2 (en) 2007-11-16 2012-05-22 Kaneka Corporation Process for production of N-carbamoyl-tert-leucine
CA2710683A1 (en) 2008-01-03 2009-07-16 Verenium Corporation Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
EP2423187A4 (de) 2009-04-24 2015-08-12 Kaneka Corp Verfahren zur herstellung von n-alkoxycarbonyl-tert.-leucinen
US8835676B2 (en) 2011-03-21 2014-09-16 Divi's Laboratories Ltd. Process for the preparation of enantiomerically pure tert-leucine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541080A (en) 1991-11-01 1996-07-30 Wisconsin Alumni Research Fdn. Method for preparing L-alpha-amino acids
US5219731A (en) * 1991-11-01 1993-06-15 Wisconsin Alumni Research Foundation Method for preparing optically-active amino acid derivatives

Also Published As

Publication number Publication date
JPH09504304A (ja) 1997-04-28
GB9322472D0 (en) 1993-12-22
DE69416424D1 (de) 1999-03-18
EP0726891A1 (de) 1996-08-21
CA2173205A1 (en) 1995-05-11
ES2128592T3 (es) 1999-05-16
EP0726891B1 (de) 1999-02-03
AU676786B2 (en) 1997-03-20
DE69416424T2 (de) 1999-06-10
AU8001294A (en) 1995-05-23
US6180374B1 (en) 2001-01-30
WO1995012573A1 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
ATE98702T1 (de) Gleichmaessiger, duenner diamantfilm sowie ein verfahren zu dessen herstellung.
DE69123944D1 (de) Verfahren zur Herstellung von Hydrogengas unter Verwendung von Mikroorganismen
AU5754190A (en) Enantiomeric enrichment and stereoselective synthesis of chiral amines
CA2083041A1 (en) Labeled compounds for use in a diagnostic breath test
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
ATE142243T1 (de) Polymer zu lichtunterstützter lichthärtung und verfahren zu seiner herstellung
DE69428912D1 (de) Verfahren zur herstellung von pentafluorethan
DE59500837D1 (de) Verfahren zur Herstellung von Acetylen und Synthesegas
DE69432152D1 (de) Mikrobielle stämme zur produktion von sphingolipidbasen
ATE176461T1 (de) Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte
ATE25676T1 (de) Optisch einheitliche beta-lactame, deren herstellung und verwendung bei der herstellung von antimikrobiell wirksamen beta-lactamen sowie vorprodukte verwendbar zu deren herstellung.
DE69612086D1 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta-lactonresten
DE69230495D1 (de) Spurenelementreiches zusatzmittel, verfahren zu dessen herstellung, diese enthaltende zusammensetzung und deren verwendung
ATE125570T1 (de) Biokatalytisches verfahren zur herstellung von l- (-)-carnitin aus crotonobetain und stämme von proteeae zur verwendung in diesem verfahren.
DE69220326D1 (de) Verfahren zur Herstellung von Trans-L-Hydroxy-Prolin
DE59606567D1 (de) Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
DE3678081D1 (de) Verfahren zur herstellung von polyaminen, polyamine und deren verwendung zur herstellung von polyurethanen.
DE59206633D1 (de) Biotechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid und R-(-)-2,2-Dimethylcyclopropancarbonsäure
EP0418770A3 (en) Process for the chemical resolution of 5-alkoxy-substituted (+/-)-1,3-dimethyloxindolylethylamines
DE69206192D1 (de) Zusammensetzung zur Herstellung von Kohlenstoffverbundmaterial, so erhaltenes Kohlenstoffverbundmaterial und Verfahren zu dessen Herstellung.
DE68913411D1 (de) Pentapeptide und Verfahren zu deren Herstellung.
DE69308934D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan
ATE283362T1 (de) Verfahren zur erhöhung der produktion von clavam- antibiotika
DE69802892D1 (de) Metallteil mit einer auswendigen oberfläche mit einem besonderen profil, polierverfahren zur herstellung desselben sowie vorrichtung zu seiner durchführung
DE69408795D1 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoffverbundmaterial

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties